Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Lymphoid 1Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

Oxaliplatin 86Capecitabine 66Bevacizumab 65Fluorouracil 48tislelizumab 41Gemcitabine 39Drug Therapy 39Leucovorin 38sintilimab 35Irinotecan 34Cisplatin 28lenvatinib 26HMPL-013 25S 1 (combination) 24camrelizumab 22Immune Checkpoint Inhibitors 21irinotecan sucrosofate 20apatinib 20Surgical Procedures, Operative 20Radiotherapy 20Injections 20130-nm albumin-bound paclitaxel 20toripalimab 18Paclitaxel 18Folfox protocol 17pembrolizumab 16Immunotherapy 15Cetuximab 15Specimen Handling 14regorafenib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Patient Reported Outcome Measures × Gastrointestinal × Clear all
NCT07211009 2025-10-07

Patient-Reported Symptom Care Versus Usual Care After Esophageal Cancer Surgery: A Single-Center Phase 3 Randomized Trial

Sichuan University

Phase 3 Not yet recruiting
240 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡